The global upper extremity implants market size is anticipated to reach USD 2.28 billion by 2030 and is projected to grow at a CAGR of 4.0% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of musculoskeletal disorders significantly influences the upper extremity implant market. Conditions such as arthritis, tendonitis, and osteoporosis are becoming more common, particularly among the aging population. According to a WHO report from July 2022, around 1.71 billion people globally suffer from musculoskeletal conditions.
These disorders often lead to impaired mobility and chronic pain, necessitating medical intervention and, in severe cases, surgical procedures involving implants. The growing awareness of these conditions and the availability of advanced diagnostic tools enable earlier detection and treatment, further driving the demand for upper extremity implants. As the global population ages, the incidence of musculoskeletal disorders is expected to increase, ensuring a steady demand for implant solutions designed to restore function and improve the quality of life for affected individuals.
Companies such as Zimmer Biomet, Stryker, Johnson & Johnson, and Smith+Nephew are at the forefront of introducing innovative implant solutions and advanced surgical techniques. Technological advancements like 3D printing, robotics, and biocompatible materials are enhancing the precision, durability, and functionality of implants, leading to improved patient outcomes and reduced recovery times. For instance, in August 2022, OSSIO, Inc. announced the launch and initial commercial use of OSSIOfiber Anchors.
This introduction expands patient access to OSSIO's growing portfolio of bio-integrative implants, which are designed for use in shoulder, hand/wrist, and elbow surgeries. These innovations enable the development of customized implants tailored to individual patient needs, increasing the adoption of these devices. The continuous efforts of these key players to innovate and improve implant technology are pivotal in driving the expansion and the market evolution.
Furthermore, the increasing participation in sports and physical activities has led to a higher incidence of sports-related injuries, which in turn drives the demand for upper extremity implants. Injuries such as fractures, dislocations, and ligament tears are common among athletes and active individuals, often requiring surgical intervention to restore functionality. The growing awareness of the benefits of early and effective treatment for sports injuries has prompted more individuals to seek medical help, leading to an increase in the number of surgical procedures involving implants. Moreover, advancements in minimally invasive surgical techniques and improved implant designs have made these procedures more effective and accessible, further fueling market growth.
Request a free sample copy or view report summary: Upper Extremity Implants Market Report
The shoulder segment held the largest share of 59.52% in 2023. The segment's growth is propelled by a rise in sports injuries, shoulder dislocations, a growing geriatric population, increasing incidence of osteoarthritis, shoulder fractures, accidents, and traumas, all contributing to higher demand for upper extremity implant products
The metallic biomaterials segment held the largest share in 2023. This can be attributed to advanced properties such as proper strength, fracture toughness, ductility, hardness, corrosion resistance, and biocompatibility
The hospitals segment held the largest share in 2023. Innovations such as robotic-assisted surgery and advanced imaging techniques enhance surgical accuracy and patient outcomes
North America market dominated the overall global market in 2023. Factors such as rising common shoulder injuries such as include dislocations/separations, sprains/strains, contusions, and fractures. The rise in the geriatric population, increasing number of sports injuries, and presence of key participants in North America are driving regional growth
The competitive scenario in the market is highly competitive, with key players holding significant positions. The major companies are undertaking various strategies such as new product development, collaborations, acquisitions, mergers, and regional expansion to serve the unmet needs of their customers
Grand View Research has segmented the global upper extremity implants market based on type, biomaterial, end-use, and region:
Upper Extremity Implants Type Outlook (Revenue, USD Million, 2018 - 2030)
Shoulder
Elbow
Hand & Wrist
Upper Extremity Implants Biomaterial Outlook (Revenue, USD Million, 2018 - 2030)
Metallic Biomaterials
Ceramic Biomaterials
Polymeric Biomaterials
Natural Biomaterials
Upper Extremity Implants End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
ASCs
Clinics
Upper Extremity Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina Mexico
Mexico
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Upper Extremity Implants Market
Stryker
DePuy
Zimmer Biomet
Smith & Nephew
Medtronic
Aesculap
BioTek Instruments
Conmed
Arthrex, Inc.
Ossur
DJO Global
Acumed LLC
"The quality of research they have done for us has been excellent..."